Clinical Trial Update: Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

A study evaluating retinal pigment epithelium derived from human embryonic stem cells for dry age-related macular degeneration in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Age-related Macular Degeneration

Drugs mentioned

• RPE derived from human embryonic stem cells

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Dry Age-related Macular Degeneration | Phase 1, Phase 2 | Status: UNKNOWN